You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Announced during the company's recent analyst day, the instrument could mark a major step in mass spectrometry's ongoing move into clinical applications.
Called the Vitamin D 200M Assay, the kit runs on Sciex's Topaz LC-MS System and is the only FDA-cleared LC-MS-based Vitamin D assay kit currently on the market.
A report from Leerink predicted Thermo Fisher Scientific could launch such a system within the next year, potentially opening up the clinical mass spec market.
Overall growth was driven by the company's diagnostics segment, which rose 11 percent, while life sciences improved 6 percent
The company has made significant progress implementing large-scale discovery workflows though challenges remain in terms of translation to the clinic.